Literature DB >> 33727699

Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group.

Jerome Amir Singh1,2, Sonali Kochhar3,4, Jonathan Wolff5.   

Abstract

Entities:  

Year:  2021        PMID： 33727699     DOI： 10.1038/s41591-021-01299-5

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Restrictions on the use of placebo in new COVID-19 vaccine trials.

Authors:  Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2021-08-30       Impact factor: 2.953

Review 2.  WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations.

Authors:  Jerome Amir Singh; Sonali Kochhar; Jonathan Wolff; Caesar Atuire; Anant Bhan; Ezekiel Emanuel; Ruth Faden; Prakash Ghimire; Dirceu Greco; Calvin Ho; Suerie Moon; Ehsan Shamsi-Gooshki; Aissatou Touré; Beatriz Thomé; Maxwell J Smith; Ross E G Upshur
Journal:  Vaccine       Date:  2022-02-28       Impact factor: 3.641

3.  SARS-CoV-2 Variants and Vaccines.

Authors:  Philip R Krause; Thomas R Fleming; Ira M Longini; Richard Peto; Sylvie Briand; David L Heymann; Valerie Beral; Matthew D Snape; Helen Rees; Alba-Maria Ropero; Ran D Balicer; Jakob P Cramer; César Muñoz-Fontela; Marion Gruber; Rogerio Gaspar; Jerome A Singh; Kanta Subbarao; Maria D Van Kerkhove; Soumya Swaminathan; Michael J Ryan; Ana-Maria Henao-Restrepo
Journal:  N Engl J Med       Date:  2021-06-23       Impact factor: 176.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.